Viera Doničová

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM)

Jan Brož, Denisa Janíčková Žďarská, Jana Urbanová et al. · Diabetes Therapy · 2018 · 37 citations · Full text

Power spectral analysis of respiratory responses to pharyngeal stimulation in cats: comparisons with eupnoea and gasping.

Z Tomori, M. L. Fung, Viliam Donič et al. · The Journal of Physiology · 1995 · 29 citations · Full text

Glycaemic Variability and Risk Factors of Pregnant Women with and without Gestational Diabetes Mellitus Measured by Continuous Glucose Monitoring

Martina Gáborová, Viera Doničová, Ivana Bačová et al. · International Journal of Environmental Research and Public Health · 2021 · 17 citations · Full text

Fear of driving license withdrawal in patients with insulin-treated diabetes mellitus negatively influences their decision to report severe hypoglycemic events to physicians

Jan Brož, Marek Brabec, Denisa Janíčková Žďarská et al. · Patient Preference and Adherence · 2015 · 16 citations · Full text